Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin

Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin In a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator's subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial mode” for its use and making it a case of regular emergency use authorisation. https://ift.tt/eA8V8J